RONIKKA HANNANS: Open Payments
NPI 1588106272 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 23 payments from 11 companies in 2025. Trend: 2023 $1,404 · 2024 $1,629 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $43 |
| Dexcom, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Alkermes, Inc. | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $19 |
| Biogen, Inc. | 1 | $19 |
| Ardelyx, Inc. | 1 | $19 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: VRAYLAR, Kerendia, Dexcom G6 Transmitter, CAPLYTA, VIVITROL, RINVOQ, ZURZUVAE, IBSRELA.
Industry payments across VA — which companies pay providers there.
